Dr. Robert L. Minor presents two complex cases of “global” renal and mesenteric ischemia in which right radial access improved visceral artery cannulation and guide support, avoided challenging aortoiliac anatomy, and facilitated multivessel...
Dr. Robert L. Minor presents two complex cases of “global” renal and mesenteric ischemia in which right radial access improved visceral artery cannulation and guide support, avoided challenging aortoiliac anatomy, and facilitated multivessel...
Sarah Misbah, MD; Alexis Albert Annan, MD; Sridevi Pitta, MD, MBA; Ashley Ferguson, RN, BSN
Misbah et al present the case of a 70-year-old female who presented with left lower extremity (LLE) critical limb ischemia (CLI) and underwent a bilateral SFA intervention via the transulnar route.
Misbah et al present the case of a 70-year-old female who presented with left lower extremity (LLE) critical limb ischemia (CLI) and underwent a bilateral SFA intervention via the transulnar route.
Drs. Usman and Zakir present 2 challenging cases that highlight how the DETOUR™ System (Endologix) was used for PTAB in complex femoropopliteal disease, including prior stenting, long-segment occlusion, and heavily calcified anatomy.
Drs. Usman and Zakir present 2 challenging cases that highlight how the DETOUR™ System (Endologix) was used for PTAB in complex femoropopliteal disease, including prior stenting, long-segment occlusion, and heavily calcified anatomy.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Dr. Robert L. Minor presents two complex cases of “global” renal and mesenteric ischemia in which right radial access improved visceral artery cannulation and guide support, avoided challenging aortoiliac anatomy, and facilitated multivessel...
Dr. Robert L. Minor presents two complex cases of “global” renal and mesenteric ischemia in which right radial access improved visceral artery cannulation and guide support, avoided challenging aortoiliac anatomy, and facilitated multivessel...
Sarah Misbah, MD; Alexis Albert Annan, MD; Sridevi Pitta, MD, MBA; Ashley Ferguson, RN, BSN
Misbah et al present the case of a 70-year-old female who presented with left lower extremity (LLE) critical limb ischemia (CLI) and underwent a bilateral SFA intervention via the transulnar route.
Misbah et al present the case of a 70-year-old female who presented with left lower extremity (LLE) critical limb ischemia (CLI) and underwent a bilateral SFA intervention via the transulnar route.
Drs. Usman and Zakir present 2 challenging cases that highlight how the DETOUR™ System (Endologix) was used for PTAB in complex femoropopliteal disease, including prior stenting, long-segment occlusion, and heavily calcified anatomy.
Drs. Usman and Zakir present 2 challenging cases that highlight how the DETOUR™ System (Endologix) was used for PTAB in complex femoropopliteal disease, including prior stenting, long-segment occlusion, and heavily calcified anatomy.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.
New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.
Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.
Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.
The TECTONIC CAD IVL trial enrolled 335 patients across 40 U.S. clinical sites, with first pivotal trial data expected to be presented at TCT later this year.
The TECTONIC CAD IVL trial enrolled 335 patients across 40 U.S. clinical sites, with first pivotal trial data expected to be presented at TCT later this year.
With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.
With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
ESC Press Release
Sophia Antipolis, France – 23 July 2026: The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the annual congress of the European Society of Cardiology, which takes...
ESC Press Release
Sophia Antipolis, France – 23 July 2026: The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the annual congress of the European Society of Cardiology, which takes...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...